Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CNMDthis companyCONMED Corporation	$51.65	26.71×	1.22×	0.92×	11.64×	119.6%	52.8%	10.3%	3.4%	4.6%	4.6%	12.0%	0.81×	4.5×	4.54×	2.14×	2.0%	8	1.96	3	B+
AHCOAdaptHealth Corp.	$7.36	-19.15×	0.89×	0.41×	6.65×	589.1%	17.5%	5.7%	-2.2%	-4.7%	5.1%	16.3%	1.25×	3.8×	1.76×	1.02×	0.0%	6	0.67	2	C+
AZTAAzenta, Inc.	$40.38	-23.54×	0.76×	2.21×	21.18×	-69.9%	45.5%	-1.9%	-9.4%	-3.2%	2.1%	2.9%	0.06×	-3.12×	0×	2.98×	0.0%	4	3.8	2	C+
ESTAEstablishment Labs Holdings Inc.	$67.14	-42.37×	91.68×	10.23×	-105.32×	-220.3%	69.3%	-18.5%	-24.2%	-216.9%	-11.9%	-2.7%	11.23×	-8.47×	-1.54×	3.04×	0.0%	3	4.36	1	D+
KMTSKestra Medical Technologies, Ltd.	$29.40	-8.53×	4.66×	12.72×	-8.45×	-619.4%	51.4%	-141.6%	-138.4%	-50.7%	-43.7%	-9.6%	0.18×	0.39×	-17.85×	4.41×	0.0%	2	5.31	1	D+
NEOGNeogen Corporation	$12.09	-223×	0.93×	2.23×	15.45×	-121.0%	46.9%	-2.5%	-0.9%	-0.4%	-0.6%	1.6%	0.38×	3.69×	-0.38×	3.82×	0.0%	6	1.45	2	C
Peer median	—	-23.54×	0.93×	2.23×	6.65×	-121.0%	46.9%	-2.5%	-9.4%	-4.7%	-0.6%	1.6%	0.38×	0.39×	-0.38×	3.04×	0.0%	4	3.8	2	—